Patent · US Active

Humanized monoclonal antibodies against activated protein C and uses thereof

US9657111B2 · kind B2 · utility

2Cited by

9References

19Claims

0Family size

Assignee

BAYER HEALTHCARE LLC · DE

Inventors

Xiao-Yan Zhao · Union City, US
Zhuozhi Wang · Millbrae, US
Ji-Yun Kim · Changwon-si, KR
Ying ZHU · Alamo, US
Jan Tebbe · Cologne, DE

Key dates

Filing date	Nov 27, 2013
Grant date	May 23, 2017
Priority date	—
Expiry date	Nov 27, 2033

Classification

Technology area (CPC G)Physics
CPC primaryG01N2333/96461
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

Provided are humanized antibodies that selectively bind to and inhibit activated protein C without binding to or inhibiting unactivated protein C. Methods of treatment employing these antibodies are described herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.